Recessive Mutations in SYNPO2 as a Candidate of Monogenic Nephrotic Syndrome

Introduction: Most of the approximately 60 genes that if mutated cause steroid-resistant nephrotic syndrome (SRNS) are highly expressed in the glomerular podocyte, rendering SRNS a “podocytopathy.” Methods: We performed whole-exome sequencing (WES) in 1200 nephrotic syndrome (NS) patients. Results:...

Full description

Bibliographic Details
Main Authors: Youying Mao, Ronen Schneider, Peter F.M. van der Ven, Marvin Assent, Keerthika Lohanadan, Verena Klämbt, Florian Buerger, Thomas M. Kitzler, Konstantin Deutsch, Makiko Nakayama, Amar J. Majmundar, Nina Mann, Tobias Hermle, Ana C. Onuchic-Whitford, Wei Zhou, Nandini Nagarajan Margam, Roy Duncan, Jonathan Marquez, Mustafa Khokha, Hanan M. Fathy, Jameela A. Kari, Sherif El Desoky, Loai A. Eid, Hazem Subhi Awad, Muna Al-Saffar, Shrikant Mane, Richard P. Lifton, Dieter O. Fürst, Shirlee Shril, Friedhelm Hildebrandt
Format: Article
Language:English
Published: Elsevier 2021-02-01
Series:Kidney International Reports
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2468024920317113
id doaj-dd37eae7f792449e9379ede47e4cb65a
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Youying Mao
Ronen Schneider
Peter F.M. van der Ven
Marvin Assent
Keerthika Lohanadan
Verena Klämbt
Florian Buerger
Thomas M. Kitzler
Konstantin Deutsch
Makiko Nakayama
Amar J. Majmundar
Nina Mann
Tobias Hermle
Ana C. Onuchic-Whitford
Wei Zhou
Nandini Nagarajan Margam
Roy Duncan
Jonathan Marquez
Mustafa Khokha
Hanan M. Fathy
Jameela A. Kari
Sherif El Desoky
Loai A. Eid
Hazem Subhi Awad
Muna Al-Saffar
Shrikant Mane
Richard P. Lifton
Dieter O. Fürst
Shirlee Shril
Friedhelm Hildebrandt
spellingShingle Youying Mao
Ronen Schneider
Peter F.M. van der Ven
Marvin Assent
Keerthika Lohanadan
Verena Klämbt
Florian Buerger
Thomas M. Kitzler
Konstantin Deutsch
Makiko Nakayama
Amar J. Majmundar
Nina Mann
Tobias Hermle
Ana C. Onuchic-Whitford
Wei Zhou
Nandini Nagarajan Margam
Roy Duncan
Jonathan Marquez
Mustafa Khokha
Hanan M. Fathy
Jameela A. Kari
Sherif El Desoky
Loai A. Eid
Hazem Subhi Awad
Muna Al-Saffar
Shrikant Mane
Richard P. Lifton
Dieter O. Fürst
Shirlee Shril
Friedhelm Hildebrandt
Recessive Mutations in SYNPO2 as a Candidate of Monogenic Nephrotic Syndrome
Kidney International Reports
monogenic kidney disease
nephrotic syndrome
SYNPO2
author_facet Youying Mao
Ronen Schneider
Peter F.M. van der Ven
Marvin Assent
Keerthika Lohanadan
Verena Klämbt
Florian Buerger
Thomas M. Kitzler
Konstantin Deutsch
Makiko Nakayama
Amar J. Majmundar
Nina Mann
Tobias Hermle
Ana C. Onuchic-Whitford
Wei Zhou
Nandini Nagarajan Margam
Roy Duncan
Jonathan Marquez
Mustafa Khokha
Hanan M. Fathy
Jameela A. Kari
Sherif El Desoky
Loai A. Eid
Hazem Subhi Awad
Muna Al-Saffar
Shrikant Mane
Richard P. Lifton
Dieter O. Fürst
Shirlee Shril
Friedhelm Hildebrandt
author_sort Youying Mao
title Recessive Mutations in SYNPO2 as a Candidate of Monogenic Nephrotic Syndrome
title_short Recessive Mutations in SYNPO2 as a Candidate of Monogenic Nephrotic Syndrome
title_full Recessive Mutations in SYNPO2 as a Candidate of Monogenic Nephrotic Syndrome
title_fullStr Recessive Mutations in SYNPO2 as a Candidate of Monogenic Nephrotic Syndrome
title_full_unstemmed Recessive Mutations in SYNPO2 as a Candidate of Monogenic Nephrotic Syndrome
title_sort recessive mutations in synpo2 as a candidate of monogenic nephrotic syndrome
publisher Elsevier
series Kidney International Reports
issn 2468-0249
publishDate 2021-02-01
description Introduction: Most of the approximately 60 genes that if mutated cause steroid-resistant nephrotic syndrome (SRNS) are highly expressed in the glomerular podocyte, rendering SRNS a “podocytopathy.” Methods: We performed whole-exome sequencing (WES) in 1200 nephrotic syndrome (NS) patients. Results: We discovered homozygous truncating and homozygous missense mutation in SYNPO2 (synaptopodin-2) (p.Lys1124∗ and p.Ala1134Thr) in 2 patients with childhood-onset NS. We found SYNPO2 expression in both podocytes and mesangial cells; however, notably, immunofluorescence staining of adult human and rat kidney cryosections indicated that SYNPO2 is localized mainly in mesangial cells. Subcellular localization studies reveal that in these cells SYNPO2 partially co-localizes with α-actinin and filamin A−containing F-actin filaments. Upon transfection in mesangial cells or podocytes, EGFP-SYNPO2 co-localized with α-actinin-4, which gene is mutated in autosomal dominant SRNS in humans. SYNPO2 overexpression increases mesangial cell migration rate (MMR), whereas shRNA knockdown reduces MMR. Decreased MMR was rescued by transfection of wild-type mouse Synpo2 cDNA but only partially by cDNA representing mutations from the NS patients. The increased mesangial cell migration rate (MMR) by SYNPO2 overexpression was inhibited by ARP complex inhibitor CK666. SYNPO2 shRNA knockdown in podocytes decreased active Rac1, which was rescued by transfection of wild-type SYNPO2 cDNA but not by cDNA representing any of the 2 mutant variants. Conclusion: We show that SYNPO2 variants may lead to Rac1-ARP3 dysregulation, and may play a role in the pathogenesis of nephrotic syndrome.
topic monogenic kidney disease
nephrotic syndrome
SYNPO2
url http://www.sciencedirect.com/science/article/pii/S2468024920317113
work_keys_str_mv AT youyingmao recessivemutationsinsynpo2asacandidateofmonogenicnephroticsyndrome
AT ronenschneider recessivemutationsinsynpo2asacandidateofmonogenicnephroticsyndrome
AT peterfmvanderven recessivemutationsinsynpo2asacandidateofmonogenicnephroticsyndrome
AT marvinassent recessivemutationsinsynpo2asacandidateofmonogenicnephroticsyndrome
AT keerthikalohanadan recessivemutationsinsynpo2asacandidateofmonogenicnephroticsyndrome
AT verenaklambt recessivemutationsinsynpo2asacandidateofmonogenicnephroticsyndrome
AT florianbuerger recessivemutationsinsynpo2asacandidateofmonogenicnephroticsyndrome
AT thomasmkitzler recessivemutationsinsynpo2asacandidateofmonogenicnephroticsyndrome
AT konstantindeutsch recessivemutationsinsynpo2asacandidateofmonogenicnephroticsyndrome
AT makikonakayama recessivemutationsinsynpo2asacandidateofmonogenicnephroticsyndrome
AT amarjmajmundar recessivemutationsinsynpo2asacandidateofmonogenicnephroticsyndrome
AT ninamann recessivemutationsinsynpo2asacandidateofmonogenicnephroticsyndrome
AT tobiashermle recessivemutationsinsynpo2asacandidateofmonogenicnephroticsyndrome
AT anaconuchicwhitford recessivemutationsinsynpo2asacandidateofmonogenicnephroticsyndrome
AT weizhou recessivemutationsinsynpo2asacandidateofmonogenicnephroticsyndrome
AT nandininagarajanmargam recessivemutationsinsynpo2asacandidateofmonogenicnephroticsyndrome
AT royduncan recessivemutationsinsynpo2asacandidateofmonogenicnephroticsyndrome
AT jonathanmarquez recessivemutationsinsynpo2asacandidateofmonogenicnephroticsyndrome
AT mustafakhokha recessivemutationsinsynpo2asacandidateofmonogenicnephroticsyndrome
AT hananmfathy recessivemutationsinsynpo2asacandidateofmonogenicnephroticsyndrome
AT jameelaakari recessivemutationsinsynpo2asacandidateofmonogenicnephroticsyndrome
AT sherifeldesoky recessivemutationsinsynpo2asacandidateofmonogenicnephroticsyndrome
AT loaiaeid recessivemutationsinsynpo2asacandidateofmonogenicnephroticsyndrome
AT hazemsubhiawad recessivemutationsinsynpo2asacandidateofmonogenicnephroticsyndrome
AT munaalsaffar recessivemutationsinsynpo2asacandidateofmonogenicnephroticsyndrome
AT shrikantmane recessivemutationsinsynpo2asacandidateofmonogenicnephroticsyndrome
AT richardplifton recessivemutationsinsynpo2asacandidateofmonogenicnephroticsyndrome
AT dieterofurst recessivemutationsinsynpo2asacandidateofmonogenicnephroticsyndrome
AT shirleeshril recessivemutationsinsynpo2asacandidateofmonogenicnephroticsyndrome
AT friedhelmhildebrandt recessivemutationsinsynpo2asacandidateofmonogenicnephroticsyndrome
_version_ 1724274644161134592
spelling doaj-dd37eae7f792449e9379ede47e4cb65a2021-02-11T04:23:31ZengElsevierKidney International Reports2468-02492021-02-0162472483Recessive Mutations in SYNPO2 as a Candidate of Monogenic Nephrotic SyndromeYouying Mao0Ronen Schneider1Peter F.M. van der Ven2Marvin Assent3Keerthika Lohanadan4Verena Klämbt5Florian Buerger6Thomas M. Kitzler7Konstantin Deutsch8Makiko Nakayama9Amar J. Majmundar10Nina Mann11Tobias Hermle12Ana C. Onuchic-Whitford13Wei Zhou14Nandini Nagarajan Margam15Roy Duncan16Jonathan Marquez17Mustafa Khokha18Hanan M. Fathy19Jameela A. Kari20Sherif El Desoky21Loai A. Eid22Hazem Subhi Awad23Muna Al-Saffar24Shrikant Mane25Richard P. Lifton26Dieter O. Fürst27Shirlee Shril28Friedhelm Hildebrandt29Department of Pediatrics, Boston Children’s Hospital, Harvard Medical School, Boston, Massachusetts, USA; Department of Nephrology, Shanghai Children’s Medical Center, Shanhai Jiaotong University, Shanghai, ChinaDepartment of Pediatrics, Boston Children’s Hospital, Harvard Medical School, Boston, Massachusetts, USAInstitute for Cell Biology, Department of Molecular Cell Biology, University of Bonn, Bonn, GermanyInstitute for Cell Biology, Department of Molecular Cell Biology, University of Bonn, Bonn, GermanyInstitute for Cell Biology, Department of Molecular Cell Biology, University of Bonn, Bonn, GermanyDepartment of Pediatrics, Boston Children’s Hospital, Harvard Medical School, Boston, Massachusetts, USADepartment of Pediatrics, Boston Children’s Hospital, Harvard Medical School, Boston, Massachusetts, USADepartment of Pediatrics, Boston Children’s Hospital, Harvard Medical School, Boston, Massachusetts, USADepartment of Pediatrics, Boston Children’s Hospital, Harvard Medical School, Boston, Massachusetts, USADepartment of Pediatrics, Boston Children’s Hospital, Harvard Medical School, Boston, Massachusetts, USADepartment of Pediatrics, Boston Children’s Hospital, Harvard Medical School, Boston, Massachusetts, USADepartment of Pediatrics, Boston Children’s Hospital, Harvard Medical School, Boston, Massachusetts, USADepartment of Pediatrics, Boston Children’s Hospital, Harvard Medical School, Boston, Massachusetts, USADepartment of Pediatrics, Boston Children’s Hospital, Harvard Medical School, Boston, Massachusetts, USA; Renal Division, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts, USADepartment of Nephrology, Shanghai Children’s Medical Center, Shanhai Jiaotong University, Shanghai, ChinaDepartment of Microbiology and Immunology, Dalhousie University, Halifax, Nova Scotia, CanadaDepartment of Microbiology and Immunology, Dalhousie University, Halifax, Nova Scotia, CanadaDepartment of Pediatrics, Yale University School of Medicine, New Haven, Connecticut, USADepartment of Pediatrics, Yale University School of Medicine, New Haven, Connecticut, USADepartment of Pediatrics, Alexandria Faculty of medicine, Alexandria University, Alexandria, EgyptDepartment of Pediatrics, King Abdulaziz University, Jeddah, Kingdom of Saudi Arabia; Pediatric Nephrology Center of Excellence, King Abdulaziz University, Jeddah, Kingdom of Saudi ArabiaDepartment of Pediatrics, King Abdulaziz University, Jeddah, Kingdom of Saudi Arabia; Pediatric Nephrology Center of Excellence, King Abdulaziz University, Jeddah, Kingdom of Saudi ArabiaPediatric Nephrology Department, Dubai Kidney Center of Excellence, Dubai Hospital, Dubai, United Arab EmiratesPediatric Nephrology Department, Dubai Kidney Center of Excellence, Dubai Hospital, Dubai, United Arab EmiratesDepartment of Pediatrics, Boston Children’s Hospital, Harvard Medical School, Boston, Massachusetts, USA; United Arab Emirates University, Abu Dhabi, United Arab EmiratesDepartment of Genetics, Yale University School of Medicine, New Haven, Connecticut, USADepartment of Genetics, Yale University School of Medicine, New Haven, Connecticut, USA; Howard Hughes Medical Institute, Chevy Chase, Maryland, USAInstitute for Cell Biology, Department of Molecular Cell Biology, University of Bonn, Bonn, GermanyDepartment of Pediatrics, Boston Children’s Hospital, Harvard Medical School, Boston, Massachusetts, USADepartment of Pediatrics, Boston Children’s Hospital, Harvard Medical School, Boston, Massachusetts, USA; Correspondence: Friedhelm Hildebrandt, Boston Children’s Hospital, Enders 561, Harvard Medical School, 300 Longwood Avenue, Boston, Massachusetts 02115, USA.Introduction: Most of the approximately 60 genes that if mutated cause steroid-resistant nephrotic syndrome (SRNS) are highly expressed in the glomerular podocyte, rendering SRNS a “podocytopathy.” Methods: We performed whole-exome sequencing (WES) in 1200 nephrotic syndrome (NS) patients. Results: We discovered homozygous truncating and homozygous missense mutation in SYNPO2 (synaptopodin-2) (p.Lys1124∗ and p.Ala1134Thr) in 2 patients with childhood-onset NS. We found SYNPO2 expression in both podocytes and mesangial cells; however, notably, immunofluorescence staining of adult human and rat kidney cryosections indicated that SYNPO2 is localized mainly in mesangial cells. Subcellular localization studies reveal that in these cells SYNPO2 partially co-localizes with α-actinin and filamin A−containing F-actin filaments. Upon transfection in mesangial cells or podocytes, EGFP-SYNPO2 co-localized with α-actinin-4, which gene is mutated in autosomal dominant SRNS in humans. SYNPO2 overexpression increases mesangial cell migration rate (MMR), whereas shRNA knockdown reduces MMR. Decreased MMR was rescued by transfection of wild-type mouse Synpo2 cDNA but only partially by cDNA representing mutations from the NS patients. The increased mesangial cell migration rate (MMR) by SYNPO2 overexpression was inhibited by ARP complex inhibitor CK666. SYNPO2 shRNA knockdown in podocytes decreased active Rac1, which was rescued by transfection of wild-type SYNPO2 cDNA but not by cDNA representing any of the 2 mutant variants. Conclusion: We show that SYNPO2 variants may lead to Rac1-ARP3 dysregulation, and may play a role in the pathogenesis of nephrotic syndrome.http://www.sciencedirect.com/science/article/pii/S2468024920317113monogenic kidney diseasenephrotic syndromeSYNPO2